LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Soon-Shiong reacquires research from buyer of his Abraxis firm.
Dr. Patrick Soon-Shiong has rolled out another health care company and announced two new high-tech care programs in the L.A. biotech billionaire’s ongoing effort to revolutionize disease treatment and health care delivery.
Health Net Inc.’s profit plummeted in the fourth-quarter as the managed-care provider was hurt by litigation costs and other expenses.
The Los Angeles City Council has voted to place a third initiative regulating medical marijuana dispensaries on the May ballot.
BIOTECH: Amgen retains their confidence despite dip in quarterly earnings.
Some analysts give Amgen a healthy prognosis despite industry giant’s drop in fourth quarter earnings.
Amgen Inc. reported a worse-than-expected 16 percent decline in fourth-quarter net income, as higher costs of marketing and production offset sales growth gains for many of its drugs.
Simulations Plus Inc. said its fiscal first-quarter net income fell 22 percent as the specialty software developer was hurt by cutbacks at some of its large customers.
Herbalife Ltd. got a boost Wednesday on word that a respected trader had taken a stake in the company. But that news was tempered by a report that securities regulators had opened an inquiry into the company.
LTC Properties Inc. said that it had purchased two land parcels and entered into health care facility development commitments valued at more than $29 million.
U.S. HealthWorks said that it has entered the Illinois market with the acquisition of three Chicago-area occupational medicine and urgent care centers.
The Gores Group has completed the acquisition of medical device maker Therakos Inc. from Johnson & Johnson’s Ortho-Clinical Diagnostics Inc.
Health Net Inc. on Thursday said it ended contracts with Tenet Healthcare Corp.’s six hospitals in Southern California over a dispute on reimbursement rates.
Shares of Herbalife Ltd., which had fallen nearly 40 percent recently, made a comeback Wednesday as investors digested the company’s response to the latest criticisms of its multilevel marketing business model.
MannKind Inc. shares rose 5 percent on Wednesday after investors learned that the biotech’s founder had acquired more shares in exchange for cancelling debt the company owed him.
Herbalife Ltd., which has long relied on contract manufacturers to make its weight loss and nutritional products, has taken additional steps to change that.
Herbalife Ltd. shares dropped more than 10 percent on Wednesday after a report that a well-known hedge fund trader had shorted the company’s stock.